Novartis Pharma US

      
TOBI is taken twice a day in a 28-day-on/28-day-off cycle.

TOBI® (Tobramycin Inhalation Solution, USP)     should be taken twice a day in a cycle of 28 days on and 28 days off. After 28 days of taking TOBI, take a 28-day break.

Here are other guidelines to follow when taking TOBI:

Doses of TOBI should be taken as close to 12 hours apart as possible, and should not be taken less than
6 hours apart

Taking TOBI requires about 15-20 minutes of nebulization time, assuming a clean and working nebulizer     and compressor are used

The time it takes to nebulize     is different for every TOBI patient. The time may go by faster by watching TV or playing a game.

The dose is the same for all patients regardless of weight, age, or other factors

Ask your doctor or Respiratory Therapist for more information about the right way to take TOBI
   
Want some tips on following the treatment cycle? Read how the Katz family does it.
 

  
What does TOBI look like?
 
 
 
   
 
Home  |  CF and Pa Infections  |  TOBI Basics  |  Treating With TOBI  |  TOBI Tools and Tips
TOBI Patient Assistance  |  Cystic Fibrosis Resources  |  Glossary of Important CF Words  |  FAQs
Get More Information  |  Prescribing Information  |  Important Safety Information  | Send an E-card
CFvoice.com
Contact Us |  Site Map |  Site Guide

Please see full Prescribing Information.

Please see Patient Prescribing Information.

Information for Patients and Caregivers
Indication
TOBI® (Tobramycin Inhalation Solution, USP) is a prescription inhaled medication for cystic fibrosis patients whose lungs contain bacteria called Pseudomonas aeruginosa. TOBI has not been studied in patients under 6 years of age, in those with a lung function outside of a certain range, or in those whose lungs contain bacteria called Burkholderia cepacia. Ask your doctor if TOBI is right for you.

IMPORTANT SAFETY INFORMATION
If you are allergic to antibiotics in the same family as TOBI (ie, aminoglycosides), you should not take TOBI. Tell your doctor before starting treatment if you have any history of hearing, kidney, balance, or muscle problems.

Patients taking TOBI may have temporary side effects like coughing or difficulty breathing. Some people taking TOBI experienced ringing in the ears, hearing loss, or changes in voice (hoarseness)   . Ringing in the ears may be a warning sign for hearing loss. If you have ringing in the ears, changes in hearing, or dizziness, you should tell your doctor.

In studies, kidney damage was not seen in patients taking TOBI. However, antibiotics in the same family as TOBI have been linked to kidney damage.

If you are pregnant, plan to become pregnant, or if you are breast-feeding, talk with your doctor before taking TOBI.

Some drugs may interact with TOBI. Discuss all medications you are taking with your doctor.

Patients with cystic fibrosis can have many symptoms. Some of these may be related to your medications. You should tell your doctor if you have new or worsening symptoms.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

TBI-800101-B
Novartis Pharma US Use of Web site is governed by the Terms of Use and Privacy Statement.
Copyright © 2010
Novartis Pharmaceuticals Corporation. All rights reserved.
Novartis proudly supports the Patient Assistance Now program.